Skip to main content
NCBI home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1965 Aug;25(1):4–17. doi: 10.1111/j.1476-5381.1965.tb01752.x

The role of ionic interaction at the muscarinic receptor

A S V Burgen
PMCID: PMC1510682  PMID: 19108209

Full text

PDF
4

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BANISTER J., WHITTAKER V. P. Pharmacological activity of the carbon analogue of acetylcholine. Nature. 1951 Apr 14;167(4250):605–606. doi: 10.1038/167605b0. [DOI] [PubMed] [Google Scholar]
  2. BARLOW R. B., SCOTT K. A., STEPHENSON R. P. AN ATTEMPT TO STUDY THE EFFECTS OF CHEMICAL STRUCTURE ON THE AFFINITY AND EFFICACY OF COMPOUNDS RELATED TO ACETYLCHOLINE. Br J Pharmacol Chemother. 1963 Dec;21:509–522. doi: 10.1111/j.1476-5381.1963.tb02019.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. ELLENBROEK B. W., van ROSSUM J. Absolute configuration and parasympathomimetic activity. Chemistry and pharmacology of acetyl-beta-methylcholine. Arch Int Pharmacodyn Ther. 1960 Apr 1;125:216–220. [PubMed] [Google Scholar]
  4. FUNCKE A. B., REKKER R. F., ERNSTING M. J., TERSTEEGE H. M., NAUTA W. T. [Studies on spasmolytics. V. Benzilic acid esters]. Arzneimittelforschung. 1959 Sep;9:573–576. [PubMed] [Google Scholar]
  5. GROSSMAN M. I., ROBERTSON C., ROSIERE C. E. The effect of some compounds related to histamine on gastric acid secretion. J Pharmacol Exp Ther. 1952 Mar;104(3):277–283. [PubMed] [Google Scholar]
  6. HAMILTON J. T. The influence of pH on the activity of nicotine at the neuromuscular junction. Can J Biochem Physiol. 1963 Feb;41:283–289. [PubMed] [Google Scholar]
  7. INOUYE A., SHINAGAWA Y., TAKAISHI Y. NOTE ON THE PHARMACOLOGICAL ROLE OF "CATIONIC HEAD" OF ACETYLCHOLINE AND ITS CONGENERS IN THE LIGHT OF ITS ELECTRONIC STRUCTURE. Arch Int Pharmacodyn Ther. 1963 Oct 1;145:546–552. [PubMed] [Google Scholar]
  8. LONG J. P., LUDUENA F. P., TULLAR B. F., LANDS A. M. Stereochemical factors involved in cholinolytic activity. J Pharmacol Exp Ther. 1956 May;117(1):29–37. [PubMed] [Google Scholar]
  9. NICKERSON M. Receptor occupancy and tissue response. Nature. 1956 Sep 29;178(4535):697–698. doi: 10.1038/178697b0. [DOI] [PubMed] [Google Scholar]
  10. ROCHA E SILVA M. On the nature of the receptors for histamine. Chemotherapia (Basel) 1961;3:544–559. doi: 10.1159/000219570. [DOI] [PubMed] [Google Scholar]
  11. SCHNEIDER R., TIMMS A. R. Some aspects of the pharmacology of an homologous series of choline esters of fatty acids. Br J Pharmacol Chemother. 1957 Mar;12(1):30–38. doi: 10.1111/j.1476-5381.1957.tb01358.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. STEPHENSON R. P. A modification of receptor theory. Br J Pharmacol Chemother. 1956 Dec;11(4):379–393. doi: 10.1111/j.1476-5381.1956.tb00006.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. WILSON I. B. Acetylcholinesterase. XII. Further studies of binding forces. J Biol Chem. 1952 May;197(1):215–225. [PubMed] [Google Scholar]
  14. van ROSSUM J., ARIENS E. J. Receptor-reserve and threshold-phenomena. II. Theories on drug-action and a quantitative approach to spare receptors and threshold values. Arch Int Pharmacodyn Ther. 1962 Apr 1;136:385–413. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES